Persistence of pregabalin treatment in Taiwan: a nation-wide population-based study.
Yen-Feng WangYung-Tai ChenChing-Wen TsaiYu-Chun YenYi-Chun ChenBen-Chang ShiaShuu-Jiun WangPublished in: The journal of headache and pain (2020)
Pregabalin prescriptions for pain disorders were limited to short-term use, which is consistent around the world. However, the average prescribed dose in Taiwan was lower than those in Western countries, and was frequently below the recommended ranges. Potential causes included the duration of natural history of PHN, and off-label prescriptions for pain in acute herpes zoster, rather than PHN, as well as intolerance to the side effects.